IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KalVista Pharmaceuticals, Inc.

CUSIP: 048349710 | 1 institutional holders

Quarters

Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2017

Vivo Capital, LLC300,325
0.0% of portfolio›$2.2K
StyleTurnoverLocationFiled
Vivo Capital, LLC
300,325$2.2K0.0%CoreMediumPalo Alto, CA2017-08-02